FIG 6.

Moderate HIV-1 reactivation following SMACm treatment of latently infected Hpt1-b renal cells and Jurkat T cells. Latently infected Hpt-1b renal cells or Jurkat T cells were flow sorted 2 weeks postinfection and cultured for an additional week before SMACm treatment. Cells were then treated for 24 h with SMACm, JQ1 or DMSO either once (a–c) or twice (b–d). Bars represent mean+SD of the percentage of GFP+ population in three independent experiments. Asterisks indicate a significant difference (P value <0.05; nonparametric Kruskall-Wallis test) between LRA treated cells and DMSO.